Tier 1 publicly traded (300199.SZ) pharmaceutical manufacturer founded 1998. 20+ years producing therapeutic peptide APIs and peptide-based drugs with registered APIs at China CDE. Capacity expansion underway.
Hybio Pharmaceutical is based in Shenzhen, Guangdong, China, specialising in Peptide APIs, GMP Manufacturing, Biological Products, Therapeutic Peptides, minimum order Contract-based.
No manufacturing licence is recorded for Hybio Pharmaceutical in our data. That is an absence of information rather than evidence of a problem, but it means nothing here has been verified against a regulator's register.
No independent assay in our records names Hybio Pharmaceutical as the manufacturer. Manufacturer attribution only appears where a certificate of analysis records it, so this is common and is not a quality signal in itself.
Manufacturer entries describe who produces a compound, not who sells it to you. For purchasing, the vendor directory records storefront reachability, assay history and FDA warning-letter history separately.
Directories: All manufacturers, Vendor directory, Independent lab tests.